Progyny Inc (PGNY)

Gross profit margin

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020
Gross profit (ttm) US$ in thousands 253,363 246,825 250,205 242,565 238,799 226,399 209,770 193,016 167,325 147,946 130,443 116,177 112,135 107,686 100,030 82,364 70,059 61,162 52,646
Revenue (ttm) US$ in thousands 1,167,818 1,140,069 1,135,369 1,111,361 1,091,902 1,036,101 959,749 874,714 787,727 700,482 617,337 551,196 501,082 473,730 450,213 385,920 344,979 309,953 272,210
Gross profit margin 21.70% 21.65% 22.04% 21.83% 21.87% 21.85% 21.86% 22.07% 21.24% 21.12% 21.13% 21.08% 22.38% 22.73% 22.22% 21.34% 20.31% 19.73% 19.34%

December 31, 2024 calculation

Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $253,363K ÷ $1,167,818K
= 21.70%

The gross profit margin of Progyny Inc has shown a relatively stable trend over the past five years, ranging from approximately 19.34% to 22.73%. The margin has generally increased from June 2020 to September 2021, reaching its peak at 22.73% in September 2021. However, after this peak, the gross profit margin fluctuated slightly but remained around the 21% mark for the most recent periods up to December 2024. The company's ability to effectively control production costs and generate revenue from its core operations has resulted in a consistent gross profit margin, indicating stable profitability in its business operations.


Peer comparison

Dec 31, 2024

Company name
Symbol
Gross profit margin
Progyny Inc
PGNY
21.70%
DaVita HealthCare Partners Inc
DVA
82.35%
Sotera Health Co
SHC
55.00%